Dr. Jawad Ahmad, MD

Dr. Ahmad practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Ahmad's NPI, 1104898311, was assigned on February 2, 2006. Dr. Ahmad graduated from Royal Free Hospital and University College London Medical School in 1992. Dr. Ahmad holds New York license 253593.

Dr. Ahmad's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Ahmad also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Ahmad's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Ahmad to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ahmad practices, 2 sites in all. Vendor and product names are available with a free account.

Hepatology is Dr. Ahmad's primary specialty in the NPI Registry, under taxonomy code 207RI0008X. Dr. Ahmad is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Ahmad's licenses on file in 3 states: New York, Florida and Pennsylvania.

Dmand AI lists bile duct problems, cirrhosis, cirrhosis of the liver, colonoscopy, gastrointestinal inflammation, liver disease, pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Ahmad treats.

CMS data shows 243 Medicare services from Dr. Ahmad across 8 procedure codes in 2024, for 104 Medicare patients. Medicare paid $18,706 for them.

CMS counts 104 Medicare patients who saw Dr. Ahmad in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 31% are also on Medicaid. Their average risk score is 3.07, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ahmad's median patient age at 58, with 43% women.

In 2024, Dr. Ahmad wrote 908 Medicare Part D claims for 89 patients. 87% of them were for generic drugs. CMS names the drug for 670 of them, across 20 drugs with 11 or more claims each, at $164,788 in total drug cost. In 2023, CMS named 733 claims across 21 drugs.

Dr. Ahmad accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ahmad as offering telehealth. CMS counts 138 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Ahmad, more than 83% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 68 papers to Dr. Ahmad, published from 2008 to 2025. 2024 was the busiest year, with 8. The most frequent topics are Chemical and Drug Induced Liver Injury, Liver Transplantation and Hepatitis C. Dr. Ahmad has published most often in Dig Dis Sci. Dr. Ahmad's most frequent co-authors are David Erwin Kleiner, MD, PhD, Andrew Abba Stolz, MD and Marwan Samir Ghabril, MD.

Dmand AI links Dr. Ahmad to 1 clinical trial. Conditions studied include Hepatorenal Syndrome and Liver Diseases. Open Payments lists research payments to Dr. Ahmad that name 1 trial.

CMS Open Payments shows 26 general payments to Dr. Ahmad from 9 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 94% of the total. Sarepta Therapeutics, Inc. paid the most, $12,953. It also lists 2 research payments totaling $3,050 from 2024 to 2025, naming 1 clinical trial.

Dr. Ahmad graduated from Royal Free Hospital and University College London Medical School in 1992.

Dr. Ahmad is in network with 18 carriers, including Aetna, United Healthcare and HCSC. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.